<DOC>
	<DOCNO>NCT00709098</DOCNO>
	<brief_summary>Patients symptomatic idiopathic ( IPAH ) familial ( FPAH ) pulmonary arterial hypertension New York Heart Association ( NYHA ) class II IV , naive PAH treatment currently treat stable dose either bosentan sildenafil complete PROWESS 15 enrol PROWESS 15 Extension study . This double-blind ( 12 week ) , randomize study compare safety tolerability inhale iloprost power disc-15 power disc-6 patient symptomatic pulmonary arterial hypertension ( PAH ) . After completion double blind period , patient enter open label period use iloprost power disc-15 .</brief_summary>
	<brief_title>Safety Study Extension Iloprost Power 15 Pulmonary Arterial Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Iloprost</mesh_term>
	<criteria>1 . Signed informed consent prior initiation study mandate procedure , 2 . Patients symptomatic idiopathic familial pulmonary arterial hypertension NYHA functional class II IV complete study AC063A301 , 3 . Women childbearing potential must negative urine pregnancy test must use adequate method contraception study 28 day discontinuation study drug . 1 . Pulmonary arterial hypertension relate condition specify inclusion criterion , 2 . Pulmonary arterial hypertension associate significant venous capillary involvement ( Pulmonary capillary wedge pressure ( PCWP ) &gt; 15 mmHg ) , know pulmonary venoocclusive disease , pulmonary capillary hemangiomatosis , 3 . Moderate severe obstructive lung disease : forced expiratory volume 1 second/forced vital capacity ( FEV1/FVC ) &lt; 70 % FEV1 &lt; 65 % predict value bronchodilator administration , 4 . Moderate severe restrictive lung disease : total lung capacity ( TLC ) &lt; 60 % predict value , 5 . Pregnant breastfeed woman , 6 . Systemic hypertension ( systolic blood pressure &gt; 160 mmHg diastolic blood pressure &gt; 100 mmHg repeat measurement ) , 7 . Systolic blood pressure &lt; 95 mmHg , 8 . Moderate severe hepatic impairment , i.e. , ChildPugh Class B C , 9 . Chronic renal insufficiency define serum creatinine &gt; 2.5 mg/dL ( 221 Î¼mol/L ) ongoing dialysis , 10 . Clinically relevant bleeding disorder active bleeding , 11 . Known hypersensitivity iloprost excipients .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>pulmonary arterial hypertension</keyword>
	<keyword>inhale treatment</keyword>
	<keyword>inhalation solution</keyword>
	<keyword>iloprost</keyword>
	<keyword>Ventavis</keyword>
</DOC>